Factors Associated With Breast Cancer Risks and Outcomes

Genomic and Non-Genomic Factors Associated With Breast Cancer Risk Factors and Outcomes

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07294703

Enrollment

750

Registered

2025-12-19

Start date

2025-12-08

Completion date

2031-12-08

Last updated

2026-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast cancer, Memorial Sloan Kettering Cancer Center, 25-335

Brief summary

The purpose of this study is to learn more about risks and outcomes of breast cancer in people with different backgrounds. Tissue and blood will be collected from participants for research purposes. Participants will complete questionnaires during their standard medical care. The study will not provide treatment for cancer or any other condition.

Interventions

OTHERSurvey

Complete surveys: * Baseline (within 6 months of enrollment) * 1st follow-up survey (approx. 6 months to 12 months) * 2nd follow-up survey and/or blood collection (approx. 3 years +/- 6 months) * 3rd follow-up survey and/or blood collection (approx. 5 years +/- 6 months)

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Women 18 years and older who are patients with a suspicious breast finding who present to breast radiology at MSK for biopsy or any new breast cancer patient seen at MSK undergoing surgery. Inclusion Criteria: A patient cannot be considered eligible for this study unless the following conditions are met. * Patients with a suspicious breast finding who present to breast radiology at MSK for biopsy or any new breast cancer patient who is a surgical candidate seen at MSK. * Women 18 years of age and older are eligible to participate in the study.

Exclusion criteria

* Patients presenting with a suspicious breast mass or breast cancer less than 1 cm. * Patients presenting to clinic with only microinvasion * Patients who are less than 18 years of age * Patients unable to complete the survey, including IDMC patients.

Design outcomes

Primary

Measure	Time frame	Description
Recurrence Free Survival/RFS	5 years	RFS as defined by the STEEP 2.0 guidelines

Countries

United States

Contacts

CONTACTNeha Goel, MD, MPH

goeln1@mskcc.org646-888-4298

CONTACTGeorge Plitas, MD

PlitasG@mskcc.org646-888-5368

PRINCIPAL_INVESTIGATORNeha Goel, MD, MPH

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 18, 2026